Resist-SMD - Identification of therapeutic targets specific to hematopoietic stem cells resistant to hypomethylating agents in myelodysplastic syndromes

Imagen proyecto Resist-SMD
Resist-SMD
National Projects
Project management unit
Resist-SMD - Identification of therapeutic targets specific to hematopoietic stem cells resistant to hypomethylating agents in myelodysplastic syndromes

The Resist-SMD project (PC24-RESIST-SMD-015-003-007) is funded by the SINAI Agents Grants for collaborative R&D projects (2024 call). It falls under the thematic priority "Personalized Medicine" identified in Navarra’s Smart Specialization Strategy (S4).

 

Coordinator:    Partners:               
                   

   

 

         
                   
                   

 

Funding organisation
Data sheet
-
Financing
Nacional
Organisation
Gobierno de Navarra
Start - End
-
Centre
Navarrabiomed
Researchers